drugset / Trial / NCT07218796
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
RandomizedParallel-groupDouble-blindTreatment
Summary
This trial is a randomized study to evaluate the Bimatoprost Implant System used in combination with the SpyGlass IOL to Timolol Ophthalmic Solution in participants with mild to moderate open-angle glaucoma or ocular hypertension undergoing cataract surgery.
Timeline
- Start
- 2025-10-28
- Primary completion
- 2029-05-31
- Completion
- 2031-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 78 ug | — |
| Comparator | Timolol | Other / unclassified | 0.5 % | — |